A Clinical Trial Study to Determine the Effect of an Investigational Drug (SEP-363856) Has on the Way That the Drug Metformin Travels Through the Body in People With Schizophrenia.

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
A clinical trial study to determine the effect of an investigational drug (SEP-363856) has on the way that the drug Metformin travels through the body in people with schizophrenia. This clinical trial will have approximately 24 subjects both male and female 18 year of age and older. This study will be conducted in approximately 2 study sites in the United States.
Epistemonikos ID: ffdcc74a4f5cacb5218deb45e60e4de384e3a67b
First added on: May 08, 2024